Correlations between complement system’s activation factors and anti-angiogenesis factors in plasma of patients with early/late-onset severe preeclampsia

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Hypertension in Pregnancy

• Publication date

  2016-06-17

• Fields of study

  Medicine

• Identifiers
  DOI 10.1080/10641955.2016.1190845PMID 27315511
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Complement factor B activation in patients with preeclampsia.

  2015cited by this paper
• Urinary Excretion of C5b‐9 is Associated With the Anti‐Angiogenic State in Severe Preeclampsia

  2015cited by this paper
• Complement Activation and Regulation in Preeclamptic Placenta

  2014cited by this paper
• Maternal and Fetal Alternative Complement Pathway Activation in Early Severe Preeclampsia

  2014cited by this paper
• Elevated complement factor C5a in maternal and umbilical cord plasma in preeclampsia.

  2013cited by this paper
• Urinary Excretion of C5b-9 in Severe Preeclampsia: Tipping the Balance of Complement Activation in Pregnancy

  2013cited by this paper
• Complement activation is critical for placental ischemia-induced hypertension in the rat.

  2013cited by this paper
• Biomarkers of Coagulation, Inflammation, and Angiogenesis are Independently Associated with Preeclampsia

  2012cited by this paper
• Autoantibody-Mediated Complement C3a Receptor Activation Contributes to the Pathogenesis of Preeclampsia

  2012cited by this paper
• Preeclampsia Is Characterized by Placental Complement Dysregulation

  2012cited by this paper
• Early Elevations of the Complement Activation Fragment C3a and Adverse Pregnancy Outcomes

  2011cited by this paper
• A Critical Review of Early-Onset and Late-Onset Preeclampsia

  2011cited by this paper
• Targeted inhibition of complement activation prevents features of preeclampsia in mice.

  2011cited by this paper
• Activation of the complement system in normal pregnancy and preeclampsia.

  2010cited by this paper
• Complement-mediated inhibition of neovascularization reveals a point of convergence between innate immunity and angiogenesis.

  2010cited by this paper
• Dysregulated complement activation as a common pathway of injury in preeclampsia and other pregnancy complications.

  2010influential reference
• The interrelationship of complement‐activation fragments and angiogenesis‐related factors in early pregnancy and their association with pre‐eclampsia

  2010cited by this paper
• Molecular Intercommunication between the Complement and Coagulation Systems

  2010cited by this paper
• Pre-eclampsia

  2010cited by this paper
• The C5b-9 membrane attack complex of complement activation localizes to villous trophoblast injury in vivo and modulates human trophoblast function in vitro.

  2008cited by this paper
• Soluble endoglin and other circulating antiangiogenic factors in preeclampsia

  2007cited by this paper
• Microarray analysis of differentially expressed fetal genes in placental tissue derived from early and late onset severe pre-eclampsia.

  2007cited by this paper
• Generation of C5a in the absence of C3: a new complement activation pathway

  2006cited by this paper
• Soluble endoglin and other circulating antiangiogenic factors in preeclampsia.

  2006cited by this paper
• Complement activation induces dysregulation of angiogenic factors and causes fetal rejection and growth restriction

  2006cited by this paper
• Circulating angiogenic factors and the risk of preeclampsia.

  2004cited by this paper
• Antibiotic use in relation to the risk of breast cancer

  2004cited by this paper
• Diagnosis and management of preeclampsia and eclampsia

  2002cited by this paper
• ACOG practice bulletin. Diagnosis and management of preeclampsia and eclampsia. Number 33, January 2002.

  2002cited by this paper
• Complement component deposition in uteroplacental (spiral) arteries in normal human pregnancy.

  1987cited by this paper

• The complement system in human pregnancy and preeclampsia

  2025cites this paper
• Predictive Value and Potential of Targeting Complement Factor C3 in Patients with Renal Injury in Preeclampsia.

  2025cites this paper
• Systematic review of the complement components as potential biomarkers of pre-eclampsia: pitfalls and opportunities

  2024cites this paper
• Is the Complement System Dysregulated in Preeclampsia Comorbid with HIV Infection?

  2024cites this paper
• Clinical implication of platelet to lymphocyte ratio in early onset preeclampsia: A single-center experience

  2023cites this paper
• A non-redundant role of complement protein C1q in normal and adverse pregnancy

  2022cites this paper
• Maternal alpha‐1‐antitrypsin as a noval marker for growth restriction in pre‐eclampsia

  2021cites this paper
• Complement activation by an angiogenic imbalance leads to systemic vascular endothelial dysfunction: A new proposal for the pathophysiology of preeclampsia.

  2021cites this paper
• Effect of magnesium sulfate combined with labetalol on serum sFlt-1/PlGF ratio in patients with early-onset severe pre-eclampsia

  2020cites this paper
• Regulation of the complement system and immunological tolerance in pregnancy.

  2019cites this paper
• The role of the complement system in HIV infection and preeclampsia

  2019cites this paper
• A Study of Platelet Parameter as a Diagnostic and Predictive Biomarker for Preeclampsia

  2019cites this paper
• Celecoxib restores angiogenic factor expression at the maternal-fetal interface in the BPH/5 mouse model of preeclampsia.

  2018cites this paper
• Omentin expression level in neonatal umbilical cord of patients with severe preeclampsia and its and clinical significance

  2018cites this paper
• Platelet count and MPV in women with PIH in their third trimester

  2018cites this paper
• G-protein receptor kinases 2, 5 and 6 redundantly modulate Smoothened-GATA transcriptional crosstalk in fetal mouse hearts.

  2018cites this paper
• Correlation of late-pregnancy serum 25-OH-VitD3 content with maternal endothelial injury and placental apoptosis

  2018cites this paper
• Angiogenic factor imbalance precedes complement deposition in placentae of the BPH/5 model of preeclampsia

  2017cites this paper
• The correlation of serum sCD40 and its ligand contents with renal injury in patients with preeclampsia

  2017cites this paper
• Effect of folic acid and vitamin supplement on endothelial injury and placental blood perfusion in patients with hypertensive disorder complicating pregnancy

  2017cites this paper
• The Pregnant Adolescent : General Considerations

  2017cites this paper
• Immunological Tolerance, Pregnancy, and Preeclampsia: The Roles of Semen Microbes and the Father

  2017cites this paper
• Correlation of mid-pregnancy uterine artery notch with preeclampsia incidence risk as well as serum endothelial injury and placental hypoperfusion

  2016cites this paper
• Vascular Health and Risk Management Dovepress Platelet Count and Platelet Indices in Women with Preeclampsia

  year unknowncites this paper